Emergent Biosolutions

Emergent BioSolutions is a global life sciences company that focuses on developing, manufacturing, and delivering medical countermeasures for public health threats, including infectious diseases, opioid overdoses, and chemical attacks. They generate revenue through government contracts, commercial sales of their products, and partnerships with other pharmaceutical companies. Founded in 1998, the company has a significant history of acquiring and developing critical vaccines and treatments, such as the anthrax vaccine BioThrax, and has played a vital role in addressing public health emergencies.

Recent Posts by Emergent Biosolutions

1-20 of 66